Extrinsic hemolytic normocytic anemia: Pathology review

13,138views

Extrinsic hemolytic normocytic anemia: Pathology review

Watch later

Watch later

Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
DNA cloning
ELISA (Enzyme-linked immunosorbent assay)
Fluorescence in situ hybridization
Gel electrophoresis and genetic testing
Karyotyping
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Acid-base map and compensatory mechanisms
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Metabolic acidosis
Plasma anion gap
Respiratory acidosis
Metabolic alkalosis
Respiratory alkalosis
Anaphylaxis
Food allergy
Type I hypersensitivity
Autoimmune hemolytic anemia
Goodpasture syndrome
Graves disease
Hemolytic disease of the newborn
Myasthenia gravis
Pemphigus vulgaris
Rheumatic heart disease
Type II hypersensitivity
Poststreptococcal glomerulonephritis
Serum sickness
Systemic lupus erythematosus
Type III hypersensitivity
Graft-versus-host disease
Type IV hypersensitivity
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
X-linked agammaglobulinemia
Adenosine deaminase deficiency
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Complement deficiency
Cytomegalovirus infection after transplant (NORD)
Chronic granulomatous disease
Leukocyte adhesion deficiency
DiGeorge syndrome
Glucocorticoids
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Contracting the immune response and peripheral tolerance
B- and T-cell memory
Vaccinations
Cytokines
Complement system
Innate immune system
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Endocarditis
Myocarditis
Cardiac tumors
Myocardial infarction
Familial hypercholesterolemia
Hypertriglyceridemia
Cushing syndrome
Hypertension
Pheochromocytoma
Polycystic kidney disease
Renal artery stenosis
Lymphedema
Peripheral artery disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Angiosarcomas
Human herpesvirus 8 (Kaposi sarcoma)
Vascular tumors
Behcet's disease
Kawasaki disease
Deep vein thrombosis
Thrombophlebitis
Adrenal cortical carcinoma
Hyperaldosteronism
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Congenital adrenal hyperplasia
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Zollinger-Ellison syndrome
Hyperprolactinemia
Pituitary adenoma
Prolactinoma
Growth hormone deficiency
Hypopituitarism
Hypoprolactinemia
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyperthyroidism
Thyroid storm
Toxic multinodular goiter
Hashimoto thyroiditis
Hypothyroidism
Postpartum thyroiditis
Thyroid cancer
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperthyroidism: Pathology review
Hypopituitarism: Pathology review
Hypothyroidism: Pathology review
Multiple endocrine neoplasia: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Hyperparathyroidism
Hypoparathyroidism
Biliary colic
Alcohol-associated liver disease
Alpha 1-antitrypsin deficiency
Autoimmune hepatitis
Benign liver tumors
Cirrhosis
Hemochromatosis
Viral hepatitis
Hepatocellular carcinoma
Jaundice
Neonatal hepatitis
Non-alcoholic fatty liver disease
Portal hypertension
Primary biliary cholangitis
Primary sclerosing cholangitis
Reye syndrome
Wilson disease
Acute pancreatitis
Chronic pancreatitis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sickle cell disease (NORD)
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Alpha-thalassemia
Anemia of chronic disease
Beta-thalassemia
Iron deficiency anemia
Sideroblastic anemia
Aplastic anemia
Mastocytosis (NORD)
Essential thrombocythemia (NORD)
Myelodysplastic syndromes
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Acute leukemia
Chronic leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Von Willebrand disease
Waldenstrom macroglobulinemia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Stevens-Johnson syndrome
Candida
Human herpesvirus 6 (Roseola)
Measles virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Coxsackievirus
Herpes simplex virus
Human papillomavirus
Ankylosing spondylitis
Gout
Rheumatoid arthritis
Septic arthritis
Osteoarthritis
Limited systemic sclerosis (CREST syndrome)
Raynaud phenomenon
Scleroderma
Sjogren syndrome
Pleural effusion
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Role of Vitamin K in coagulation
Amino acids and protein folding
Cell cycle
DNA damage and repair
DNA mutations
DNA replication
DNA structure
Epigenetics
Gene regulation
Mitosis and meiosis
Nuclear structure
Nucleotide metabolism
Transcription of DNA
Translation of mRNA
Cell membrane
Cell signaling pathways
Cell-cell junctions
Cellular structure and function
Endocytosis and exocytosis
Nernst equation
Osmosis
Acute intermittent porphyria
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anti-tumor antibiotics
DNA alkylating medications
Monoclonal antibodies
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Blood components
Erythropoietin
Bacillus anthracis (Anthrax)
Bacillus cereus (Food poisoning)
Corynebacterium diphtheriae (Diphtheria)
Listeria monocytogenes
Clostridium botulinum (Botulism)
Clostridium difficile (Pseudomembranous colitis)
Clostridium perfringens
Clostridium tetani (Tetanus)
Actinomyces israelii
Nocardia
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Streptococcus viridans
Enterococcus
Bacteroides fragilis
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Enterobacter
Escherichia coli
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Proteus mirabilis
Pseudomonas aeruginosa
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Serratia marcescens
Shigella
Yersinia enterocolitica
Yersinia pestis (Plague)
Campylobacter jejuni
Helicobacter pylori
Vibrio cholerae (Cholera)
Moraxella catarrhalis
Neisseria gonorrhoeae
Neisseria meningitidis
Bordetella pertussis (Whooping cough)
Brucella
Francisella tularensis (Tularemia)
Haemophilus ducreyi (Chancroid)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium avium complex (NORD)
Mycobacterium leprae
Chlamydia pneumoniae
Chlamydia trachomatis
Gardnerella vaginalis (Bacterial vaginosis)
Mycoplasma pneumoniae
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Borrelia burgdorferi (Lyme disease)
Borrelia species (Relapsing fever)
Leptospira
Treponema pallidum (Syphilis)
Adenovirus
Hepatitis B and Hepatitis D virus
Epstein-Barr virus (Infectious mononucleosis)
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Prions (Spongiform encephalopathy)
Norovirus
Hepatitis C virus
West Nile virus
Yellow fever virus
Zika virus
Influenza virus
Human parainfluenza viruses
Mumps virus
Respiratory syncytial virus
Hepatitis A and Hepatitis E virus
Poliovirus
Rhinovirus
Rotavirus
HIV (AIDS)
Rabies virus
PDE5 inhibitors
Protease inhibitors
Cell wall synthesis inhibitors: Cephalosporins
Serotonin and norepinephrine reuptake inhibitors
Cell wall synthesis inhibitors: Penicillins
Monoamine oxidase inhibitors
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Anemia of chronic disease: Year of the Zebra
Myeloproliferative disorders: Pathology review
Leukemias: Pathology review
Coagulation disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Platelet disorders: Pathology review
Plasma cell disorders: Pathology review
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Methemoglobinemia
Pulmonary edema
Pulmonary embolism
Pulmonary shunts
Ventilation
Prerenal azotemia
Postrenal azotemia
Renal azotemia
Hyperkalemia
Hypermagnesemia
Hypercalcemia
Hypernatremia
Hypokalemia
Hyponatremia
Amyloidosis
Vitamin D
Antidiuretic hormone
Sodium homeostasis
Renin-angiotensin-aldosterone system
Parkinson disease
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Thyroid and parathyroid gland histology
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Hypoglycemics: Insulin secretagogues
Insulins
Miscellaneous hypoglycemics
Cortisol
Synthesis of adrenocortical hormones
Parathyroid hormone
Calcitonin
Phosphate, calcium and magnesium homeostasis
Adrenocorticotropic hormone
Growth hormone and somatostatin
Oxytocin and prolactin
Thyroid hormones
Celiac disease
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Bacterial structure and functions
Herpesvirus medications
Hepatitis medications
Trypanosoma cruzi (Chagas disease)
Plasmodium species (Malaria)

Transcript

Watch video only

At the family medicine center, two people came in with progressive fatigue.

One of them is a 60 years old named Will whose past medical history included an aortic valve replacement with a mechanical valve due to severe aortic stenosis.

There’s Hanna, a 28 years old female of African descent.

She was diagnosed a year ago with systemic lupus erythematosus, or SLE. CBC is ordered for both people and it shows low hemoglobin with normal mean corpuscular volume, or MCV and reticulocyte count index over 2%.

They also have increased LDH. Now, Will has schistocytes on peripheral blood smear, while Hanna has spherocytes.

Both Will and Hannah are suffering from anemia, which is defined as lower than average levels of hemoglobin, typically below 13.5 g/dL in adult men and below 12.0 g/dL in adult women.

For children, this level varies based on the age. Now, anemias can be broadly grouped into 3 categories based on =MCV, which reflects the volume of an RBC.

So microcytic anemia is where the MCV is lower than 80 fL, normocytic, with an MCV between 80 and 100 fL, and macrocytic, with an MCV larger than 100 fL.

Normocytic anemias can be further classified as hemolytic when there’s increased destruction of RBCs, or hemolysis, and non-hemolytic when there’s decreased production of RBCs from the bone marrow.

When there’s hemolysis, the bone marrow revs up and starts pumping out immature RBCs called reticulocytes, but when there’s a bone marrow problem reticulocyte count is low.

So for your exams, it’s important to know that in hemolytic anemias there’s an increased reticulocyte production index of over 2%, while in non-hemolytic anemias it’s lower than 2%.

Alright, now hemolytic anemias can be classified as intrinsic or extrinsic hemolytic anemias.

In intrinsic hemolytic anemias, RBCs are destroyed because they’re defective, while in extrinsic hemolytic anemias, RBCs are normal but are later destroyed outside the bone marrow.

In this video, let’s focus on extrinsic hemolytic anemias that include autoimmune hemolytic anemia, microangiopathic hemolytic anemia, macroangiopathic hemolytic anemia and infections.

Now, we can divide extrinsic hemolysis into intravascular, meaning RBCs are destroyed within the vasculature, or extravascular, meaning that they are removed by macrophages in the spleen and liver.

Microangiopathic and macroangiopathic hemolytic anemias are intravascular, autoimmune hemolytic anemia is usually extravascular, while infections can cause both intravascular and extravascular.

There are findings that can help identify the type of hemolysis. In intravascular hemolysis, hemoglobin that is released inside the vessels gets bound by a protein called haptoglobin and because they’re removed together, haptoglobin decreases.

Also, when haptoglobin gets overwhelmed, the rest of hemoglobin goes via the blood through the kidneys and into the urine resulting in hemoglobinuria.

Now, when hemoglobin is inside the renal tubules, the cells lining the renal tubules reabsorb hemoglobin.

The heme component of hemoglobin contains iron which is stored as hemosiderin in tubular cells and after a few days, when tubular cells slough into urine, there’s hemosiderinuria. Hemoglobinuria and hemosiderinuria can damage the kidneys causing back pain.

Okay, now in extravascular hemolysis, RBCs are destroyed outside the vessels and so, haptoglobin is normal and there’s no hemoglobin or hemosiderin in the urine.

RBCs are usually destroyed in the spleen causing splenomegaly or the liver causing hepatomegaly.

Alright, now whenever there’s RBC lysis, an intracellular enzyme called lactate dehydrogenase, or LDH, spills out directly into the plasma and builds up in the blood.

Hemoglobin also spills out of the cell and breaks up into globin and heme.

Heme is converted into unconjugated, or indirect, bilirubin which is then taken up by the liver cells and eventually secreted out with bile.

If all of a sudden, your body starts breaking down more RBCs than the liver cells can handle, the excess bilirubin stays in the blood and cause jaundice where the bilirubin deposits in the skin and the eyes, causing them to turn yellow.

Also, when there’s too much bilirubin in the bile, it can form pigmented gallstones.

Some of the bilirubin is converted to urobilin which is what gives urine that yellow color, but if there’s too much of it, the urine becomes a much darker, tea-like color.

Okay, so let’s take a closer look at these different extrinsic hemolytic anemias, starting with autoimmune hemolytic anemia where antibodies and complement are directed against RBCs, leading to their destruction.

It’s like the RBC equivalent of immune thrombocytopenic purpura, or ITP, a disorder where autoantibodies bind to the platelet receptor and cause them to be targeted by immune cells in the spleen for destruction.

In fact, some patients develop both conditions together, and that’s called Evan’s syndrome.

Based on the type of antibodies produced, autoimmune hemolytic anemia can be divided further into IgG, also called warm antibody, hemolytic anemia, and IgM hemolytic anemia, also called cold agglutinin disease.

Now, it’s important to remember the causes, since they might be the best clues for identifying autoimmune hemolytic anemia in the exams.

Warm antibody hemolytic anemia is typically seen in chronic lymphocytic leukemia, or CLL, systemic lupus erythematosus, or SLE, and with the use of antibiotics like penicillins and cephalosporins, sulfa drugs, and the antihypertensive drug, methyldopa.

Cold agglutinin disease is often seen in CLL, Waldenstrom macroglobulinemia, a rare type of malignant lymphoma, and infections like infectious mononucleosis and mycoplasma pneumoniae infections.

Next up is microangiopathic hemolytic anemia that occurs in the small blood vessels and include thrombotic thrombocytopenic purpura, or TTP, hemolytic-uremic syndrome, or HUS, and disseminated intravascular coagulation, or DIC.

In these disorders, there’s excessive clot formation so when normal RBCs flow through these blood vessels, they get banged up and damaged, leading to intravascular hemolysis.

In TTP, there’s a deficiency of ADAMTS-13, a metalloproteinase that breaks Von willebrand factor, a protein needed for the formation of clots and their adhesion to the endothelial lining.

So When there’s not enough ADAMTS-13, there’s excessive clot formation, and these clots end up damaging RBCs.

TTP can be caused by a genetic mutation or it can develop after exposure to antiplatelet medications like ticlopidine and clopidogrel, or chemotherapeutic agents like cyclosporine and gemcitabine.

In some cases it can also be associated with diseases like systemic lupus erythematosus.

Alright, moving onto HUS. Typical HUS, occurs after an infection by a shiga-toxin bacteria.

The most common is Escherichia coli, but others include shigella, and salmonella.

A high yield fact for your exams is that this often occurs in children after an episode of gastroenteritis caused by these bacteria.

The toxins they release destroys colonic epithelial cells, causing bloody diarrhea, and then enters the circulation, where it damages the endothelial cells causing massive release of von willebrand factor and excessive clot formation throughout the body.

Typical HUS has good prognosis. Now, the atypical HUS is not associated with shiga-toxin, may occur at any age, and has a relatively poor prognosis.

It is linked to a genetic mutation in factor H, a protein that controls the complement system. Without it, the complement system goes wild, causing damage to the endothelial cells and excessive clot formation.

Next up is DIC, where there is a massive overactivation of the coagulation system in response to something like sepsis or trauma.

This leads to widespread clotting, organ ischemia, and microangiopathic hemolytic anemia, while at the same time depletes platelets and clotting factors, which paradoxically, leads to bleeding.

Sources

  1. "Kaplan USMLE Step 2 CK Lecture Notes Internal Medicine" Kaplan Medical (2017)
  2. "Robbins Basic Pathology" Elsevier (2017)
  3. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  4. "Hemolytic Anemia: Evaluation and Differential Diagnosis" Am Fam Physician (2018)
  5. "Autoimmune hemolytic anemia" Hematology (2018)
  6. "Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review" Wiener klinische Wochenschrift (2008)
  7. "Hemolytic uremic syndrome" Türk Pediatri Arşivi (2015)
  8. "Haemolytic uremic syndrome: diagnosis and management" F1000Research (2019)
  9. "Management of thrombotic thrombocytopenic purpura: current perspectives" Journal of Blood Medicine (2014)
  10. "Thrombotic microangiopathies: a general approach to diagnosis and management" Canadian Medical Association Journal (2016)
  11. "Relationships between anaemia and parasitic infections in Kenyan schoolchildren: A Bayesian hierarchical modelling approach" International Journal for Parasitology (2008)